logo

For the Inventor, By the Inventor

Wellesley Hills, MA, United States of America

Graham J Durant

This inventor holds 29 USPTO granted patents, primarily in Pharmaceutical Compounds. Top assignees: Cambridge Neuroscience, Inc., The University of Toledo, Scion Pharmaceuticals, Inc.. Active years: 1992-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Graham J Durant. Retrieved from https://idiyas.com/inventor/graham-j-durant-bw56x6gr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 29

% Patents Active = 89.7

Average Co-Inventor Count = 3.4

ph-index = 8

Forward Citations = 291(Granted Patents)


Location History:

  • Toledo, OH (US) (1992 - 1997)
  • Cambridge, MA (US) (1997 - 2001)
  • Plymouth, GB (2004 - 2006)
  • Marshfield, MA (US) (1996 - 2008)
  • Wellesley Hills, MA (US) (2000 - 2008)

Company Filing History:

goldMedal15 out of 43 
 
Cambridge Neuroscience, Inc.
 patents
silverMedal8 out of 369 
 
The University of Toledo
 patents
bronzeMedal2 out of 4 
 
Scion Pharmaceuticals, Inc.
 patents
4. 2 out of 1,309 
 
Wyeth
 patents
5. 1 out of 1 
 
Cambridge Neurosciences, Inc.
 patent
6. 1 out of 3 
 
Cenes Pharmaceuticals, Inc.
 patents
7. 1 out of 17 
 
Gliatech, Inc.
 patents
8. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1992-2008

Loading Chart...
Areas of Expertise:
Pharmaceutically Active Compounds
Therapeutic Guanidines
Nitrogen Ring Compounds
Histamine Antagonists
Muscarinic Agonists
Substituted Guanidines
Synthesis Processes
H.sub.3 Receptor
Intermediates Preparation
29 patents (USPTO):Explore Patents
1. 7423059 - Pharmaceutically active compounds and methods of use (2008-09-09),
2. 7351743 - Therapeutic guanidines (2008-04-01),
3. 7041702 - Pharmaceutically active compounds and methods of use (2006-05-09),
4. 6787569 - Therapeutic guanidines (2004-09-07),
5. 6774263 - Pharmaceutically active compound and methods of use (2004-08-10),
6. 6770668 - Pharmaceutically active compounds and methods of use (2004-08-03),
7. 6756389 - Pharmaceutically active compounds and methods of use (2004-06-29),
8. 6514990 - Pharmaceutically active compounds and methods of use (2003-02-04),
9. 6358993 - Pharmaceutically active nitrogen ring compounds and methods of use thereof (2002-03-19),
10. 6288123 - Therapeutic guanidines (2001-09-11),
11. 6174924 - Therapeutic guanidines (2001-01-16),
12. 6156741 - Therapeutic substituted guanidines (2000-12-05),
13. 6153604 - Therapeutic substituted guanidines (2000-11-28),
14. 6147063 - Therapeutic substituted guanidines (2000-11-14),
15. 6143791 - Therapeutic guanidines (2000-11-07),

Title: The Innovative Journey of Graham J Durant

Introduction: Graham J Durant, a distinguished inventor hailing from Wellesley Hills, MA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Graham J Durant's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device aimed at improving patient care in hospitals.

Career Highlights: With over two decades of experience in the tech industry, Graham J Durant has a proven track record of developing innovative solutions to complex problems. His expertise lies in artificial intelligence, data analytics, and cybersecurity.

Collaborations: Throughout his career, Graham J Durant has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His collaborative spirit has led to the successful implementation of cutting-edge technologies in various sectors.

Conclusion: Graham J Durant's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions to the tech industry continue to inspire future generations of inventors and pave the way for a more technologically advanced world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…